Cargando…

Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo

BACKGROUND: Cyclooxygenase-2(COX-2) promotes carcinogenesis, tumor proliferation, angiogenesis, prevention of apoptosis, and immunosuppression. Meanwhile, COX-2 over-expression has been associated with tumor behavior and prognosis in several cancers. This study investigated the antitumor effects of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Zhi-Jun, Ma, Xiao-Bin, Kang, Hua-Feng, Gao, Jie, Min, Wei-Li, Guan, Hai-Tao, Diao, Yan, Lu, Wang-Feng, Wang, Xi-Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558357/ https://www.ncbi.nlm.nih.gov/pubmed/23249419 http://dx.doi.org/10.1186/1475-2867-12-53

Ejemplares similares

Celecoxib: a selective cyclooxygenase-2 inhibitor
por: Gandelman, M
Publicado: (2003)

Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2
por: Park, Won, et al.
Publicado: (2008)

Effects of a selective cyclooxygenase-2 inhibitor (celecoxib) on fracture healing in rats
por: Li, Kang-Hua, et al.
Publicado: (2013)

In Vitro and In Vivo Antitumor Activity of Scutellaria barbate Extract on Murine Liver Cancer
por: Dai, Zhi-Jun, et al.
Publicado: (2011)

The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor on Noise- Induced Hearing Loss
por: Pourbakht, Akram
Publicado: (2013)

Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo
por: Pyrko, Peter, et al.
Publicado: (2006)

Novaferon, a novel recombinant protein produced by DNA-shuffling of IFN-α, shows antitumor effect in vitro and in vivo
por: Li, Meng, et al.
Publicado: (2014)

Combined Effects of Cyclooxygenase-1 and Cyclooxygenase-2 Selective Inhibitors on Ovarian Carcinoma in Vivo
por: Li, Wei, et al.
Publicado: (2011)

In vitro assessment of antitumor activities of the PI3K/mTOR inhibitor GSK2126458
por: Albawardi, Alia, et al.
Publicado: (2014)

Cyclooxygenase-2 inhibitor celecoxib attenuates joint contracture following immobilization in rat knees
por: Ozawa, Junya, et al.
Publicado: (2016)

Antitumor activity of arsenite in combination with tetrandrine against human breast cancer cell line MDA-MB-231 in vitro and in vivo
por: Yuan, Bo, et al.
Publicado: (2018)

Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum
por: NINOMIYA, ITASU, et al.
Publicado: (2012)

Myricetin enhance chemosensitivity of 5-fluorouracil on esophageal carcinoma in vitro and in vivo
por: Wang, Lei, et al.
Publicado: (2014)

Functional promoter -765 G > C variant in COX-2 gene is associated with the susceptibility of breast cancer in Chinese Han women
por: Gao, Jie, et al.
Publicado: (2014)

[(123)I]-Celecoxib Analogues as SPECT Tracers of Cyclooxygenase-2 in Inflammation
por: Uddin, Md. Jashim, et al.
Publicado: (2010)

Suppression of Occurrence and Advancement of β‐Catenin‐accumulated Crypts, Possible Premalignant Lesions of Colon Cancer, by Selective Cyclooxygenase‐2 Inhibitor, Celecoxib
por: Yamada, Yasuhiro, et al.
Publicado: (2001)

Overexpression of p65 attenuates celecoxib-induced cell death in MDA-MB-231 human breast cancer cell line
por: Wang, Ling, et al.
Publicado: (2013)

Inhibitory effect of celecoxib on agomelatine metabolism in vitro and in vivo
por: He, Jiayang, et al.
Publicado: (2018)

Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway
por: Liu, Bing, et al.
Publicado: (2017)

Antiproliferative and apoptotic effects of β-elemene on human hepatoma HepG2 cells
por: Dai, Zhi-Jun, et al.
Publicado: (2013)

Direct non-cyclooxygenase-2 targets of celecoxib and their potential relevance for cancer therapy
por: Schönthal, A H
Publicado: (2007)

Suppressing growth and invasion of human hepatocellular carcinoma cells by celecoxib through inhibition of cyclooxygenase-2
por: Tai, Yang, et al.
Publicado: (2019)

Silencing of AURKA augments the antitumor efficacy of the AURKA inhibitor MLN8237 on neuroblastoma cells
por: Yang, Yan, et al.
Publicado: (2020)

Clinical value of detecting IQGAP3, B7-H4 and cyclooxygenase-2 in the diagnosis and prognostic evaluation of colorectal cancer
por: Cao, Huihua, et al.
Publicado: (2019)

Celecoxib impairs primary human myoblast proliferation and differentiation independent of cyclooxygenase 2 inhibition
por: Matheny, Ronald W., et al.
Publicado: (2022)

Establishment and characterization of a patient-derived circulating lung tumor cell line in vitro and in vivo
por: Que, Zujun, et al.
Publicado: (2019)

SLC4A4 promotes prostate cancer progression in vivo and in vitro via AKT-mediated signalling pathway
por: Liu, Zelin, et al.
Publicado: (2022)

CDK2-AP1 inhibits growth of breast cancer cells by regulating cell cycle and increasing docetaxel sensitivity in vivo and in vitro
por: He, Xiangming, et al.
Publicado: (2014)

Development of stealth liposomal formulation of celecoxib: In vitro and in vivo evaluation
por: Begum, M. Yasmin, et al.
Publicado: (2022)

Antitumor effect of lysine-isopeptides
por: Szende, B, et al.
Publicado: (2002)

Blocking circ-SCMH1 (hsa_circ_0011946) suppresses acquired DDP resistance of oral squamous cell carcinoma (OSCC) cells both in vitro and in vivo by sponging miR-338-3p and regulating LIN28B
por: Qiu, Feng, et al.
Publicado: (2021)

ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma
por: Liu, Yalu, et al.
Publicado: (2019)

Impact of a selective cyclooxygenase-2 inhibitor, celecoxib, on cortical excitability and electrophysiological properties of the brain in healthy volunteers: A randomized, double-blind, placebo-controlled study
por: Lim, Jung-Ah, et al.
Publicado: (2019)

The synergistic anticancer effect of the bromodomain inhibitor OTX015 and histone deacetylase 6 inhibitor WT-161 in osteosarcoma
por: Yu, Bo, et al.
Publicado: (2022)

Low-dose cyclooxygenase-2 (COX-2) inhibitor celecoxib plays a protective role in the rat model of neonatal necrotizing enterocolitis
por: Sun, Ling
Publicado: (2021)

The expression profiles and prognostic values of HSP70s in hepatocellular carcinoma
por: Wang, Ben, et al.
Publicado: (2021)

Association between genetic polymorphisms in AURKA (rs2273535 and rs1047972) and breast cancer risk: a meta-analysis involving 37,221 subjects
por: Dai, Zhi-Jun, et al.
Publicado: (2014)

ADT‐OH synergistically enhanced the antitumor activity of celecoxib in human colorectal cancer cells
por: Xu, Huangru, et al.
Publicado: (2023)

Antitumor efficacy of cytosine deaminase-armed vaccinia virus plus 5-fluorocytosine in colorectal cancers
por: Ding, Yuedi, et al.
Publicado: (2020)

Induction of apoptosis and proliferation inhibition of hepatocellular carcinoma by 6-chloro-2-methoxy-N-(phenylmethyl)-9-acridinamine (BA): in vitro and vivo studies
por: Huang, Yun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5n2ht4tln7m67ncuila66rvmqm